This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Inogen One G3 Found Significantly More Versatile In Portable Oxygen Concentrator Comparison Report

SANTA BARBARA, Calif., June 13, 2013 /PRNewswire/ --  Inogen, Inc., a manufacturer and accredited homecare provider of oxygen therapy equipment and services, today announced that the 4.8 pound Inogen One® G3 portable oxygen concentrator (POC) was reviewed as the top performer in many categories among four portable oxygen concentrators in a recent report by an independent third party testing service with expertise in respiratory products, administered by Strategic Dynamics Inc.

(Photo:  http://photos.prnewswire.com/prnh/20130613/LA31751-a)

(Logo:    http://photos.prnewswire.com/prnh/20130613/LA31751LOGO-b)

The methods and results of the study were published in a white paper titled "Comparison of Four Under 5 lb. Portable Oxygen Concentrators." The purpose of the study, according to the report, was to "measure and compare the performance of four commercially available POCs in terms of their oxygen production, purity and delivery to a simulated patient as a function of breathing frequency." Among the POCs tested, the Inogen One G3 ranked the highest in terms of overall performance.

The study's findings highlight two key factors: one) how much oxygen is delivered at each breathing frequency/setting, and two) the concentrators' ability to compensate for breathing changes. Each concentrator was tested on a number of clinical criteria, and the Inogen One G3 excelled in every key clinical factor tested including pulse flow, pulse timing, trigger pressure, and pulse delay.

The summation of all the tests conducted showed the Inogen One G3 to be the highest performing POC in oxygen production and versatility:

"In translating these data to potential clinical applications, the Inogen One® G3 produces more oxygen, can maintain oxygen delivery for a higher range of patient breathing rates and is therefore significantly more versatile in managing the variability of patient oxygen demand throughout different activities."

"Providing oxygen therapy products that are both clinically efficacious and patient preferred are the core values behind the Inogen brand," said Byron Myers, Inogen Co-Founder and VP of Marketing.  "We're pleased that the research conducted by Strategic Dynamics highlights the clear cut differences in clinical application of the featured POCs and that the Inogen One G3 has been recognized as superior in these key areas."

The Inogen One G3 portable oxygen concentrator was released in the Fall of 2012, and is the smallest and lightest oxygen concentrator that Inogen carries.  At only 4.8 pounds, the Inogen One G3 has four flow settings and produces more oxygen per minute than all of the other portable concentrators reviewed in the study.

About Inogen:

Inogen is innovation in oxygen therapy. Our mission is to improve freedom and independence for oxygen therapy patients through innovative products and services.  As a manufacturer and Accredited Homecare Provider dedicated to oxygen therapy, Inogen is ideally suited to develop products tailored to oxygen therapy users and to provide superior service to those users in their homes.  For more information, visit the Company's website at www.inogen.net or the product website at www.inogenone.com

SOURCE Inogen, Inc.

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,055.87 -116.81 -0.68%
S&P 500 1,982.77 -11.52 -0.58%
NASDAQ 4,508.6880 -19.0010 -0.42%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs